Synteract

Phase 3 Clinical Trials > Trial Services

Synteract is a full-service CRO with a successful two-decade track record supporting biopharmaceutical and medical device companies through the clinical development process. We have conducted Phase I-IV studies on six continents and 60+ countries, in multiple therapeutic areas. Our “Shared Work – Shared Vision” approach helps bring tomorrow’s treatments to patients.

 

 

Contact

Jack Shannon Sr. Vice President, Business Development Phone: 760-268-8200
www.synteract.com/
5909 Sea Otter Place Carlsbad, CA 92010 USA